Literature DB >> 6237317

Second-generation antidepressants.

M V Rudorfer, R N Golden, W Z Potter.   

Abstract

The host of newly developed antidepressant drugs offer important clinical advantages to some patients, although their promises of improved therapeutic efficacy and reduced adverse effects compared with conventional treatments are not fully realized. Increased biochemical specificity and unique mechanistic or clinical profiles render these compounds valuable in research into the pathophysiology of affective disorders and mode of action of antidepressant agents.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6237317

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN： 0193-953X


  9 in total

Review 1.  The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants.

Authors:  Norbert Thuerauf; Jens Lunkenheimer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.270

2.  Reduction of prothrombin and partial thromboplastin times with trazodone.

Authors:  J L Hardy; A Sirois
Journal:  CMAJ       Date:  1986-12-15       Impact factor: 8.262

Review 3.  The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors:  M V Rudorfer; W Z Potter
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

Review 4.  Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs.

Authors:  M V Rudorfer; W Z Potter
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 5.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993

6.  The comparative efficacy of trazodone and imipramine in the treatment of depression.

Authors:  S B Patten
Journal:  CMAJ       Date:  1992-04-01       Impact factor: 8.262

7.  Reboxetine: a preliminary report on its use through the Special Access Program.

Authors:  Sidney H Kennedy; Raymond W Lam; Nicole L Cohen; Michael Rosenbluth; Stephen T H Sokolov; Roger S McIntyre; Pierre Chue; Gerry Craigen
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

Review 8.  Metabolism of tricyclic antidepressants.

Authors:  M V Rudorfer; W Z Potter
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

Review 9.  Comparative tolerability profiles of the newer versus older antidepressants.

Authors:  M V Rudorfer; H K Manji; W Z Potter
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.